mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.2 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
1 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.1 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
8e-05 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.05 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.06 |